Kronox Lab Sciences Ltd. AGM Voting Results: All Resolutions Passed, Final Dividend Approved
Kronox Lab Sciences Limited's AGM on September 16, 2026, saw all resolutions passed. Shareholders approved the FY26 standalone financial statement and a final dividend of ₹0.50 per share for FY25-26. The re-appointment of a director and cost auditor remuneration were also ratified.
The passing of financial statements and dividend declaration are standard procedures but positively impact shareholder confidence. The re-appointment of a director and ratification of auditor remuneration are routine corporate actions. The overall impact is medium as it confirms ongoing business operations and shareholder returns.
The announcement reports that all resolutions, including the adoption of financial statements, declaration of dividend, director re-appointment, and ratification of cost auditor remuneration, were passed at the AGM. This indicates positive outcomes for the company and its shareholders.
Kronox Lab Sciences Limited has announced the voting results and the combined scrutinizer's report for its 16th Annual General Meeting (AGM) held on September 16, 2026. All resolutions presented at the meeting were passed by the shareholders.
The resolutions included the adoption of the Audited Standalone Financial Statement for the financial year ended March 31, 2026. Shareholders also approved the declaration of a final dividend of ₹0.50 per equity share for the financial year 2025-26. Additionally, the re-appointment of Mr. Jogindersingh Jaswal as a Director, who retired by rotation, was approved. The remuneration payable to the Cost Auditors for the financial year 2026-27 was also ratified.
The AGM commenced at 11:00 AM and concluded at 12:45 PM on September 16, 2026. The record date for determining the shareholders eligible for the dividend was September 9, 2026. The voting results indicate strong support for all resolutions, with a significant percentage of votes polled in favor.
What to do with a filing like this
Kronox Lab Sciences Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kronox Lab Sciences Limited. Read the original for the full detail.